Small Molecule Inhibitors of Programmed Cell Death Ligand 1 (PD-L1): A Patent Review (2019 –2021)

.

Source: Expert Opinion on Therapeutic Patents - March 11, 2022 Category: Drugs & Pharmacology Authors: Jingjing Deng Zhengqi Cheng Juyang Long Alexander D ömling Micky Tortorella Yuanze Wang Source Type: research